Showing 3,741 - 3,760 results of 12,750 for search '"therapeutics"', query time: 0.07s Refine Results
  1. 3741

    Daratumumab for Bortezomib-Refractory Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allograft: A Case Report by Zewei Chen, Shangxi Fu, Jun Wu, Xiaoling Luo, Zhiguo Mao, Dechao Xu, Xiang Gao

    Published 2025-02-01
    “…The standard management of PGNMID has been unclear, currently based on data from small cohorts, which requires a need for additional therapeutic regimens in this disease. A human IgG monoclonal antibody that targets CD38 (daratumumab) was recently identified as a potential therapeutic option for treating PGNMID. …”
    Get full text
    Article
  2. 3742

    Role of PPARα and Its Agonist in Renal Diseases by Ching-Feng Cheng, Hsi-Hsien Chen, Heng Lin

    Published 2010-01-01
    “…In clinical application, PPAR-α activators, such as hypolipidemic drugs in fibric acid class, were proven to have therapeutic effects on metabolic syndrome and cardiovascular disease. …”
    Get full text
    Article
  3. 3743

    Trillin inhibits MAP3K11/NF-κB/COX-2 signaling pathways through upregulation of miR-145-5p in castration-resistant prostate cancer by Yanlong Wang, Yulin Peng, Wenjun Hao, Chengjian He, Xiang Gao, Peng Liang, Haolin Zhao, Ying Wang, Liang Wang, Zhenlong Yu, Zhiyu Liu

    Published 2025-02-01
    “…These findings suggest that Trillin may offer a promising alternative approach for targeting CRPC, highlighting its potential as a therapeutic agent to improve patient outcomes.…”
    Get full text
    Article
  4. 3744

    Gut Microbiota Secondary Metabolites: Key Roles in GI Tract Cancers and Infectious Diseases by Eman K. E. Anwer, Muhammad Ajagbe, Moustafa Sherif, Abobaker S. Musaibah, Shuaib Mahmoud, Ali ElBanbi, Anwar Abdelnaser

    Published 2025-01-01
    “…Conversely, these same metabolites hold therapeutic promise, potentially enhancing responses to chemotherapy and immunotherapy and even directly suppressing tumor growth. …”
    Get full text
    Article
  5. 3745

    6-Octadecenoic and Oleic Acid in Liquid Smoke Rice Husk Showed COVID-19 Inhibitor Properties by Ira Arundina, Neni Frimayanti, Meircurius Dwi Condro Surboyo, Theresia Indah Budhy, Benni Iskandar

    Published 2024-01-01
    “…In recent years, liquid smoke rice husk (LSRH) has shown its therapeutic potency to diabetes, wound healing, stomatitis, and periodontitis. …”
    Get full text
    Article
  6. 3746

    Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities by Mohammad Burhan Uddin, Zhishan Wang, Chengfeng Yang

    Published 2025-01-01
    “…Abstract Significant advances in the development of new cancer therapies have given rise to multiple novel therapeutic options in chemotherapy, radiotherapy, immunotherapy, and targeted therapies. …”
    Get full text
    Article
  7. 3747

    Sex hormones and immune regulation in ovarian cancer by Rui Zhao, Wenqin Lian, Qiong Xu

    Published 2024-12-01
    “…The review also discusses the therapeutic implications of these interactions, including the potential for combining hormone-based therapies with immune checkpoint inhibitors. …”
    Get full text
    Article
  8. 3748

    Transplant Tolerance: New Insights and Strategies for Long-Term Allograft Acceptance by Paulina Ruiz, Paula Maldonado, Yessia Hidalgo, Alejandra Gleisner, Daniela Sauma, Cinthia Silva, Juan Jose Saez, Sarah Nuñez, Mario Rosemblatt, Maria Rosa Bono

    Published 2013-01-01
    “…One of the greatest advances in medicine during the past century is the introduction of organ transplantation. This therapeutic strategy designed to treat organ failure and organ dysfunction allows to prolong the survival of many patients that are faced with no other treatment option. …”
    Get full text
    Article
  9. 3749

    Superparamagnetic Bifunctional Bisphosphonates Nanoparticles: A Potential MRI Contrast Agent for Osteoporosis Therapy and Diagnostic by Y. Lalatonne, M. Monteil, H. Jouni, J. M. Serfaty, O. Sainte-Catherine, N. Lièvre, S. Kusmia, P. Weinmann, M. Lecouvey, L. Motte

    Published 2010-01-01
    “…A bone targeting nanosystem is reported here which combined magnetic contrast agent for Magnetic Resonance Imaging (MRI) and a therapeutic agent (bisphosphonates) into one drug delivery system. …”
    Get full text
    Article
  10. 3750

    MUSIC THERAPY: INNOVATIVE STRATEGIES AND SOLUTIONS FOR A MULTIDISCIPLINARY APPROACH TO DESIGN SPACES WITH HIGH ACOUSTIC PERFORMANCES by Diletta Romagnolo, Angelo Bertolazzi, Giorgio Croatto, Eleonora Strada, Umberto Turrini

    Published 2024-11-01
    “…To respond to these critical issues, various modular building solutions with specific functions (therapeutic and administrative) have been evaluated. …”
    Get full text
    Article
  11. 3751

    miR-301a-mediated crosstalk between the Hedgehog and HIPPO/YAP signaling pathways promotes pancreatic cancer by Bing Qi, Yuqiong Wang, Xian Zhu, Yanfang Gong, Jing Jin, Hongyu Wu, Xiaohua Man, Feng Liu, Wenzhu Yao, Jun Gao

    Published 2025-12-01
    “…Pancreatic ductal adenocarcinoma (PDAC) poses a significant challenge in oncology due to its dismal prognosis and limited therapeutic options. In this study, we investigated the role of miR-301a in facilitating crosstalk between the Hedgehog (Hh) and HIPPO/YAP signaling pathways during the progression of PDAC. …”
    Get full text
    Article
  12. 3752

    𝛽-Thalassemia: HiJAKing Ineffective Erythropoiesis and Iron Overload by Luca Melchiori, Sara Gardenghi, Stefano Rivella

    Published 2010-01-01
    “…The processes are intimately linked such that an ideal therapeutic approach should address all of the complications. …”
    Get full text
    Article
  13. 3753

    Current status and innovative developments of CAR-T-cell therapy for the treatment of breast cancer by Hany E. Marei, Khaled Bedair, Anwarul Hasan, Layla Al-Mansoori, Sara Caratelli, Giuseppe Sconocchia, Alice Gaiba, Carlo Cenciarelli

    Published 2025-01-01
    “…We discuss in detail the role of tumor-associated antigens in breast cancer, current clinical trials, barriers to the intended therapeutic effects of CAR-T cell therapy, and potential ways to increase treatment efficacy. …”
    Get full text
    Article
  14. 3754

    Network Pharmacology, Molecular Docking, and Molecular Dynamics Analysis of Honokiol against Triple-negative Breast Cancer by Hassan H. Alhassan

    Published 2024-12-01
    “…Natural compounds have garnered significant interest as potential therapeutic agents against TNBC due to their diverse pharmacological activities. …”
    Get full text
    Article
  15. 3755

    Early Electroacupuncture Extends the rtPA Time Window to 6 h in a Male Rat Model of Embolic Stroke via the ERK1/2-MMP9 Pathway by Xin-chang Zhang, Ya-hui Gu, Wen-tao Xu, Yang-yang Song, Ao Zhang, Zhi-hui Zhang, Si-yuan Jiang, Si-qi Chang, Guang-xia Ni

    Published 2020-01-01
    “…The present study was conducted to test the hypothesis that EA extends the therapeutic time window of rtPA for ischemic stroke in a male rat model of embolic stroke. …”
    Get full text
    Article
  16. 3756

    Effect of Acarbose on High Carohydrate Diet Induced Liver Injury in Largemouth Bass (Micropterus salmoides) by Yanhao CAO, Xiaolong BO, Hongli LIU, Xiaoli HUANG

    Published 2024-11-01
    “…Among the six traditional Chinese medicines, cinnamon has a better therapeutic effect and has a similar effect to acarbose. …”
    Get full text
    Article
  17. 3757

    Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy by Jing Chen, Dan He, Chengrun Yuan, Na Li, Baohong Shi, Conway Niu, Jiangfei Yang, Liangkai Zheng, Lin Che, Ren Xu

    Published 2025-03-01
    “…This study not only enlarged the therapeutic potential of targeting cuproptosis for treating FGFR3 mutation-related HCH but also provided a novel perspective on the role of the HSPB6-ERK-Drp1-FDX1 signaling pathway in the development of HCH. …”
    Get full text
    Article
  18. 3758

    Administration of anticoagulation strategies for portal vein thrombosis in cirrhosis: network meta-analysis by Hui-Jun Li, Fu-Qiang Yin, Yu-Tong Ma, Teng-Yu Gao, Yu-Ting Tao, Xin Liu, Xian-Feng Shen, Chao Zhang

    Published 2025-01-01
    “…This study aims to comprehensively compare the therapeutic effects of different therapeutic therapeutic measures in individuals suffering from cirrhosis with PVT, with the ultimate goal of providing evidence-based recommendations for thrombolytic therapy in this population.MethodsStarting from 20 October 2023, a comprehensive search about therapeutic strategies for portal vein thrombosis in cirrhosis was conducted on PubMed, EMBASE, and Cochrane Library.Results19 studies were eventually incorporated into this study. …”
    Get full text
    Article
  19. 3759

    Intrahepatic False Aneurysm: A Complication of Needle Biopsy by C. Wm Cole, John Lorimer, Lorraine B. Le Grand-Westfall

    Published 1989-01-01
    “…The authors discuss therapeutic options for this unusual entity.…”
    Get full text
    Article
  20. 3760

    Case Report of Synchronous Prostate, Hepatocellular, and Rectal Carcinomas and Review of the Literature by Viktoria Lamprou, Daniel Paramythiotis, Dimitrios Giakoustidis, Anestis Karakatsanis, Athanasios Astreinidis, Moysis Moysidis, Antonios Mihalopoulos, Stefanos Finitsis

    Published 2020-01-01
    “…We report a case of synchronous prostate, hepatocellular, and rectal carcinomas and discuss our therapeutic strategy that resulted in excellent clinical results.…”
    Get full text
    Article